Back to top
more

Align Technology (ALGN)

(Delayed Data from NSDQ)

$236.97 USD

236.97
475,681

-1.09 (-0.46%)

Updated Oct 3, 2024 03:59 PM ET

After-Market: $232.00 -4.97 (-2.10%) 5:18 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value D Growth A Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 29% (178 out of 252)

Industry: Medical - Dental Supplies

Better trading starts here.

Zacks News

Align Technology (ALGN) Beats on Q1 Earnings and Revenues

Align Technology Inc. (ALGN) reported adjusted earnings per share (EPS) of 85 cents in the first quarter of 2017, up 70% from 50 cents posted in the year-ago quarter.

    Can Penumbra (PEN) Spring a Surprise this Earnings Season?

    Penumbra Inc. (PEN) is slated to release first-quarter 2017 results on May 9, after market close.

      Medical Product Stocks' Earnings on Apr 27: ZBH, RMD & More

      Let's take a look at the major Medical products stocks slated to release their Jan-Mar 2017 quarter's reports on Apr 27.

        Top Ranked Momentum Stocks to Buy for April 26th

        Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, April 26th:

          Align Technology (ALGN) Q1 Earnings: A Beat in the Cards?

          Align Technology, Inc. (ALGN) to beat expectations when it reports first-quarter fiscal 2017 results, after the market closes on Apr 27.

            Anthem (ANTM) to Report Q1 Earnings: A Beat in the Cards?

            We expect Anthem Inc. (ANTM) to beat expectations when it reports first-quarter 2017 results on Apr 26, before the market opens.

              Align (ALGN) Up 6.8% Since Earnings Report: Can It Continue?

              Align (ALGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

                Align (ALGN) Upgraded to Buy on Invisalign System Prospects

                On Apr 11, leading provider of dental and oral care solutions, Align Technology Inc. (ALGN) was raised to a Zacks Rank #2 (Buy).

                  What's in Store for Walgreens Boots (WBA) in Q2 Earnings?

                  Walgreens Boots Alliance, Inc (WBA) is slated to release second-quarter 2017 results, before the market opens on Apr 5.

                    Align Partners Zfx GmbH to Expand iTero Scanner Business

                    Align Technology Inc. (ALGN) announced a non-exclusive agreement with digital prosthetic solutions maker, Zfx GmbH on iTero Element intraoral scanners.

                      Align's iTero Hits 1 Billion Mark, Boosts Scanner Business

                      Align Technology Inc. (ALGN) has recently revealed that more than one million scans have been submitted using its iTero Element scanner in less than two years.

                        Align Technology Hits a 52-Week High on Solid Prospects

                        Share price of San Jose, CA-based Align Technology, Inc. (ALGN) reached a new 52-week high of $110.87 on Mar 15, eventually closing a bit lower at $110.31.

                          Align Expands Internationally with Dental Couture Buyout

                          Align Technology (ALGN) has recently announced the acquisition of Dubai, UAE and Nicosia, Cyprus-based distributor, G.L. Dental Couture Limited.

                            Align Technology (ALGN) Q4 Earnings and Revenues in Line

                            Align Technology Inc. (ALGN) reported adjusted earnings of 67 cents per share in the fourth quarter of 2016, up 11.6% from 60 cents in the year-ago quarter.

                              Align Poised On Global Expansion & Invisalign Teen Growth

                              On Jan 10, 2017, we issued an updated research report on California-based Align Technology Inc. (ALGN).

                                Illumina (ILMN) Launches NovaSeq Series for $100 Genome

                                Illumina, Inc. (ILMN) recently unveiled the NovaSeq Series, a scalable sequencing solution expected to enable a $100 genome.

                                  QIAGEN (QGEN) Buys OmicSoft, Expands Bioinformatics Suite

                                  QIAGEN N.V. (QGEN) recently announced the acquisition of Cary, NC-based OmicSoft Corporation.

                                    LLabCorp: Reimbursement Scenario a Drag Amid Other Woes

                                    On Jan 09, we issued an updated research report on Burlington, NC-based Laboratory Corporation of America Holdings (LH) or LabCorp.

                                      ResMed and Dr. Oz Form SleepScore Labs for Sleep Disorders

                                      ResMed Inc. (RMD) recently formed a joint venture with renowned surgeon and television host Dr. Mehmet Oz and private equity firm Pegasus Capital Advisors, L.P.

                                        Myriad Genetics: Evidence Street Reviews EndoPredict Test

                                        Myriad Genetics, Inc. (MYGN) recently announced that Blue Cross Blue Shield Association's technical assessment provider Evidence Street has reviewed its EndoPredict assay.

                                          Walgreens Boots (WBA) Beats Q1 Earnings, Trims EPS View

                                          Walgreens Boots Alliance, Inc. (WBA) reported adjusted earnings per share (EPS) of $1.10 in first-quarter fiscal 2017, up 6.8% from the year-ago quarter.

                                            Bruker Buys InVivo Biotech, Boosts MALDI Biotyper Suite

                                            Bruker Corporation (BRKR) recently announced the buyout of Hennigsdorf, Germany-based InVivo Biotech Services GmbH.

                                              Bruker Buys SCiLS, Expands in Mass Spectrometry Imaging

                                              Bruker Corporation (BRKR) recently announced the acquisition of Bremen, Germany-based software solutions developer, SCiLS GmbH.

                                                ResMed Achieves Key Milestone in Sleep-Disordered Breathing

                                                After one billion nights of sleep data was downloaded using ResMed's remote patient monitoring platform AirView, the company reached a landmark in the field of sleep research and treatment of sleep apnea.

                                                  Hologic (HOLX) Receives PMA for Aptima HIV-1 Quant Assay

                                                  Hologic, Inc. (HOLX) recently announced the receipt of the FDAs Premarket Approval (PMA) for its Aptima HIV-1 Quant assay.